<!DOCTYPE HTML>
<!--
	Strongly Typed by HTML5 UP
	html5up.net | @ajlkn
	Free for personal and commercial use under the CCA 3.0 license (html5up.net/license)
-->
<html>
	<head>
		<title> TDP43 Database </title>
		<meta charset="utf-8" />
		<link rel="icon" type="image/x-icon" href="static/images/1.png">
		<meta name="viewport" content="width=device-width, initial-scale=1, user-scalable=no" />
		<link rel="stylesheet" href="static/css/main.css" />
	</head>
	<body class="homepage is-preload">
		<div id="page-wrapper">

			<!-- Header -->
				<section id="header">
					<div class="container">

						<!-- Logo -->
							<h1 id="logo"><a href="/">TDP43 Database</a></h1>
							<p>A currated databse of mutations in TAR DNA-binding protein 43 (TDP-43)</p>

						<!-- Nav -->
							<nav id="nav">
								<ul>
									<li><a class="icon solid fa-home" href="index.html" class="current" >Introduction</a></li>
									<li>
										<a href="/" class="icon fa-chart-bar"><span>Mutation Analysis</span></a>
										<ul>
											<li><a href="sequence.html">Sequence</a></li>
											<li><a href="structure.html">Structure</a></li>
											<li><a href="kinetics.html">Kinetics</a></li>
										</ul>
									<li><a class="icon solid fa-cog" href="TP.html"><span>Therapeutics</span></a></li>
									<li><a class="icon solid fa-retweet" href="help.html"><span>Help</span></a></li>
									<li><a class="icon solid fa-sitemap" href="contact.html"><span>Contact</span></a></li>
								</ul>
							</nav>

					</div>
				</section>

<!-- Features -->
				<section id="features">
					<div class="container">
						<header>
							<h2>Effect of mutations in <strong> TDP-43 </strong> protein</h2>
						</header>
						<div class="row aln-center">
							<div class="col-4 col-6-medium col-12-small">

								<!-- Feature -->
									<section>
										<a href="#" class="image featured"><img src="static/images/1.tif" alt="" /></a>
										<header>
											<h3><strong>TDP-43</strong></h3>
										</header>
										<p>Tar Dna binding protien 43 is encoded by TARDBP gene. It is 414 AA with 4 domains and acts as a transcriptional repressor</p>
									</section>

							</div>
							<div class="col-4 col-6-medium col-12-small">

								<!-- Feature -->
									<section>
										<a href="#" class="image featured"><img src="static/images/2.png" alt="" /></a>
										<header>
											<h3><strong>TDP-43 Mutations</strong></h3>
										</header>
										<p> Mutations in TDP-43 are associated with Proteopathies including Amyotrophic Lateral Sclerosis <strong>(ALS)</strong> and Frontotemporal lobal degeneration <strong>(FTLD)</strong></p>
									</section>

							</div>
							<div class="col-4 col-6-medium col-12-small">

								<!-- Feature -->
									<section>
										<a href="#" class="image featured"><img src="static/images/3.tif" alt="" /></a>
										<header>
											<h3><strong>Therapeutics</strong></h3>
										</header>
										<p> Varying natural and synthetic inhibtors are studies and reported aginst the TDP-43 proteiopatheis</p>
									</section>
						</div>
					</div>
				</section>

			<!-- Banner -->
				<section id="banner">
					<div class="container" style="color: palevioletred;">
						<p>TDP-43 was identified as the major pathological protein in sporadic <strong>ALS</strong> and in the most common pathological subtype of FTD, frontotemporal lobar degeneration with ubiquitinated inclusions (FLTD).</p>
					</div>
				</section>

			<!-- Main -->
				<section id="main">
					<div class="container">
						<div class="row aln-center">

							<!-- Content -->
								<div id="content" class="col- col-12-medium">

									<!-- Post -->
										<article class="box post" class="row">
											<header>
												<h2><a href="#"> TDP-43 protein aggregation </a></h2>
											</header>
											<a href="#" class="image featured"><img src="static/images/4.jpg" alt="" /></a>
											<h3>Mechanism of TDP-43 aggregation</h3>
											<p>FTLD is heterogenous neurodegeneratie disorder involving frontal and temporal lobes.Three major proteins like FUS, TAR DNA binding protein and TAU  are involved in this mechanism.Post synaptic formation by fus is a early disease marker of FTLD.FTLD shows stratial involvement of both efferent system components  and glutametargic inputs from cerebral cortics.The caudate nucleus is primarly associated with behqaviour abnormality and cognitive involvement in FTLD .It has cytoplasmic inclusions consisting of cleaved form of TDP 43 protein.It has two hypothesis gain of toxicity and loss of function.FTLD patients show upper and lower symptoms.</p>
										</article>
										</section>

								</div>

						</div>
					</div>
				</section>
			<!-- Footer -->

					<div id="copyright" class="container">
						<ul class="links">
							<li>&copy; Srinivasan Ekambaram. All rights reserved.</li><li> 
							<a href="https://www.ssebioinformatics.com" target="_blank"><u>Department of Bioinformatics,</u> </a>
      <a href="https://www.saveetha.com" target="_blank"><u>Saveetha School of Engineering </u></a>, Thandalam, Chennai 602105, India.</div> </span>
						</ul>
					</div>
				</section>

		</div>

		<!-- Scripts -->
			<script src="static/js/jquery.min.js"></script>
			<script src="static/js/jquery.dropotron.min.js"></script>
			<script src="static/js/browser.min.js"></script>
			<script src="static/js/breakpoints.min.js"></script>
			<script src="static/js/util.js"></script>
			<script src="static/js/main.js"></script>

	</body>
</html>
